A score-based predictive risk model for all-cause mortality in type 2 diabetes mellitus
| Criteria | Score | |
| Age | >70 | 1 |
| Male | Male | 1 |
| Complete blood count | ||
| Neutrophil-lymphocyte ratio | >2.85 | 1 |
| Baseline anemia | Present | 2 |
| Lipid profile | ||
| High-density lipoprotein-cholesterol (mmol/L) | <1.10 or>1.67 | 1 |
| Total cholesterol (mmol/L) | <5.60 or>6.50 | 1 |
| Total triglyceride (mmol/L) | >1.24 | 1 |
| Comorbidity | ||
| Renal diabetic complication | Present | 1 |
| Ophthalmological diabetic complication | Present | 1 |
| Peripheral vascular disease | Present | 1 |
| Ischemic stroke | Present | 1 |
| Sudden cardiac death | Present | 1 |
| Atrial fibrillation | Present | 1 |
| Heart failure | Present | 1 |
| Intracranial hemorrhage | Present | 1 |
| Dementia | Present | 2 |
| Hypertension | Present | 1 |
| Chronic obstructive pulmonary disease | Present | 1 |
| Cancer | Present | 1 |
| Fasting blood glucose and HbA1C: baseline mean and measures of variability | ||
| Mean HbA1c (%) | <6.34 or>7.52 | 1 |
| Mean FBG (mmol/L) | >6.12 | 1 |
| SD: FBG | >1.63 | 1 |
| SD: HbA1c | >0.79 | 1 |
Cut-off for age is rounded to the nearest whole number.
FBG, fasting blood glucose.